# Benitec Biopharma Inc. — Form D

Benitec Biopharma Inc. of HAYWARD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-25. The offering totals $40.0M, of which $40.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-04-25
- Form: D
- Accession: 0001012975-24-000183
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $40.0M
- Investors: 17
- Date of first sale: 2024-04-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-511623

## Issuer

- Name: Benitec Biopharma Inc.
- CIK: 0001808898
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3940 TRUST WAY, HAYWARD, CA, 94545
- Phone: (510) 780-0819

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Jerel Banks | Director | Hayward, CA |
| Megan Boston | Director | Hayward, CA |
| J. Kevin Buchi | Director | Hayward, CA |
| Peter Kevin Francis | Director | Hayward, CA |
| Edward Kevin Smith | Director | Hayward, CA |
| Jerel Banks | Executive Officer | Hayward, CA |
| Megan Boston | Executive Officer | Hayward, CA |

## More

- [CIK 1808898 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1808898&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001012975-24-000183.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.